ArticleDiagnostics (Basel, Switzerland)2022

Is Omalizumab Related to Ear and Labyrinth Disorders? A Disproportionality Analysis Based on a Global Pharmacovigilance Database.

Hyeon Tae Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.